<code id='A3D444ACDE'></code><style id='A3D444ACDE'></style>
    • <acronym id='A3D444ACDE'></acronym>
      <center id='A3D444ACDE'><center id='A3D444ACDE'><tfoot id='A3D444ACDE'></tfoot></center><abbr id='A3D444ACDE'><dir id='A3D444ACDE'><tfoot id='A3D444ACDE'></tfoot><noframes id='A3D444ACDE'>

    • <optgroup id='A3D444ACDE'><strike id='A3D444ACDE'><sup id='A3D444ACDE'></sup></strike><code id='A3D444ACDE'></code></optgroup>
        1. <b id='A3D444ACDE'><label id='A3D444ACDE'><select id='A3D444ACDE'><dt id='A3D444ACDE'><span id='A3D444ACDE'></span></dt></select></label></b><u id='A3D444ACDE'></u>
          <i id='A3D444ACDE'><strike id='A3D444ACDE'><tt id='A3D444ACDE'><pre id='A3D444ACDE'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:2
          Two researchers look at a computer monitor showing a graph and other data
          Adobe

          Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

          Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

          advertisement

          The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          VC firm RA Capital starts a new synthetic biology incubator
          VC firm RA Capital starts a new synthetic biology incubator

          AdobeVenturecapitalfirmRACapitalisstartinganewincubator,settingthestageforthefirmtocreatenewstartups

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

          PhotobyKEREMYUCEL/AFPviaGettyImagesSANFRANCISCO—MayoClinichassignedSiliconValleytechstartupCerebrasa